TYF-ABCD1

N/A

Report date: 2023/10/26 17:01:34

Base Information

Drug NameTYF-ABCD1
Drug Alias NameTYF-ABCD1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionABCD1 gene stimulants
TargetsATP Binding Cassette Subfamily D Member 1
Therapy Area/IndicationsAdrenoleukodystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShenzhen Geno-Immune Medical Institute
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Geno-Immune Medical Institute
Inactive CompaniesN/A
Active IndicationsAdrenoleukodystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A